Multiple Sclerosis Clinical Trials in Chicago

Showing 221-240 of 346 trials

Fall Prevention Program for Non-ambulatory Wheeled Mobility Device Users Living With MS

NCT03705364

A research study to examine the effectiveness of a fall management program to prevent falls and develop fall recovery strategies for wheeled mobility device users living with Multiple Sclerosis.

Multiple Sclerosis

University of Illinois at Urbana-Champaign120 participantsStarted Mar 2018

Atlanta, Georgia, United States • Chicago, Illinois, United States • Urbana, Illinois, United States

COMPLETEDPHASE32.2 miles

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01846611

The purpose of this study is to assess the efficacy and safety of trabectedin+DOXIL as a third-line chemotherapy regimen (treatment) in patients with platinum-sensitive advanced-relapsed epithelial ovarian, primary peritoneal, or fallopian tube cancer who received 2 previous lines of platinum-based chemotherapy.

Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms

Janssen Research & Development, LLC581 participantsStarted Oct 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +135 more locations

Fall Prevention Program for Non-ambulatory Wheeled Mobility Device Users Living With MS

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Multiple Sclerosis Trials in Other Cities

Physiology of Interregional Connectivity in the Human Brain

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

TARGET Intracranial Aneurysm Coiling Registry

NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Study Evaluating HKI-272 in Tumors

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants

Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility Study

Other Conditions in Chicago